Guidance Document for Industry - Review of Drug Brand Names
To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-07
Data overview
- Formats
- HTML
- File languages
- English, French